Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Bonetto

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 26, 2020
Focus on the heterogeneity of amyotrophic lateral sclerosisCaterina Bendotti, Valentina Bonetto, Elisabetta Pupillo, et al.
Experimental Neurology|February 8, 2024
Changes in glial cell activation and extracellular vesicles production precede the onset of disease symptoms in transgenic hSOD1<sup>G93A</sup> pigsMaria Teresa Golia, Roberto Frigerio, Susanna Pucci, et al.
NPJ Parkinson'S Disease|December 10, 2025
JNK3 quantification in plasma: a novel biomarker for neuronal damage in Parkinson's diseaseElena Vacchi, Arianna Giani, Nunzio Perta, et al.
Molecular Neurodegeneration|August 11, 2021
Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosisLaura Pasetto, Stefano Callegaro, Alessandro Corbelli, et al.
Muscle & Nerve|November 21, 2018
A pilot trial of RNS60 in amyotrophic lateral sclerosisSabrina Paganoni, Mohamad J Alshikho, Sarah Luppino, et al.
Frontiers in Immunology|January 2, 2023
Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestationsValentina Bonetto, Laura Pasetto, Ilaria Lisi, et al.
Brain Communications|September 18, 2024
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trialGiulia Gianferrari, Riccardo Cuoghi Costantini, Valeria Crippa, et al.
Microorganisms|July 8, 2020
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern ItalyLorenzo Cavagna, Elena Seminari, Giovanni Zanframundo, et al.
Nature Communications|June 7, 2024
Multiomic ALS signatures highlight subclusters and sex differences suggesting the MAPK pathway as therapeutic targetLucas Caldi Gomes, Sonja Hänzelmann, Fabian Hausmann, et al.
Neurobiology of Disease|November 25, 2018
Motor neuron degeneration, severe myopathy and TDP-43 increase in a transgenic pig model of SOD1-linked familiar ALSPaola Crociara, Maria Novella Chieppa, Elena Vallino Costassa, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 26, 2020
Focus on the heterogeneity of amyotrophic lateral sclerosisCaterina Bendotti, Valentina Bonetto, Elisabetta Pupillo, et al.
Experimental Neurology|February 8, 2024
Changes in glial cell activation and extracellular vesicles production precede the onset of disease symptoms in transgenic hSOD1<sup>G93A</sup> pigsMaria Teresa Golia, Roberto Frigerio, Susanna Pucci, et al.
NPJ Parkinson'S Disease|December 10, 2025
JNK3 quantification in plasma: a novel biomarker for neuronal damage in Parkinson's diseaseElena Vacchi, Arianna Giani, Nunzio Perta, et al.
Molecular Neurodegeneration|August 11, 2021
Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosisLaura Pasetto, Stefano Callegaro, Alessandro Corbelli, et al.
Muscle & Nerve|November 21, 2018
A pilot trial of RNS60 in amyotrophic lateral sclerosisSabrina Paganoni, Mohamad J Alshikho, Sarah Luppino, et al.
Frontiers in Immunology|January 2, 2023
Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestationsValentina Bonetto, Laura Pasetto, Ilaria Lisi, et al.
Brain Communications|September 18, 2024
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trialGiulia Gianferrari, Riccardo Cuoghi Costantini, Valeria Crippa, et al.
Microorganisms|July 8, 2020
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern ItalyLorenzo Cavagna, Elena Seminari, Giovanni Zanframundo, et al.
Nature Communications|June 7, 2024
Multiomic ALS signatures highlight subclusters and sex differences suggesting the MAPK pathway as therapeutic targetLucas Caldi Gomes, Sonja Hänzelmann, Fabian Hausmann, et al.
Neurobiology of Disease|November 25, 2018
Motor neuron degeneration, severe myopathy and TDP-43 increase in a transgenic pig model of SOD1-linked familiar ALSPaola Crociara, Maria Novella Chieppa, Elena Vallino Costassa, et al.
Pageof 9